HT
$55.43
-0.39
(-0.70%)
As of Oct 22, 2026, 9:29 PM EDT
Price history
Heartflow Inc (HTFL) is trading down at $55.43 (-0.70%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: August 8, 2025 · $19.00 offering · NASDAQ · View IPO details →
Heartflow Inc revenue & net income history (FY2023–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|
| Income statement | |||
| Revenue | $87.2M | $125.8M | $176.0M |
| Growth (year over year) | — | +44.3% | +39.9% |
| Gross profit | $58.1M | $94.4M | $135.2M |
| Gross margin | 66.6% | 75.1% | 76.8% |
| Operating income | −$72.9M | −$61.2M | −$64.1M |
| Operating margin | −83.6% | −48.7% | −36.4% |
| Net income | −$95.7M | −$96.4M | −$116.8M |
| Net margin | −109.7% | −76.6% | −66.3% |
| EPS (diluted) | −$25.32 | −$17.98 | −$3.17 |
| Balance sheet | |||
| Cash and equivalents | $122.8M | $51.4M | $44.8M |
| Total assets | — | $118.7M | $359.5M |
| Total liabilities | — | $209.6M | $58.8M |
| Shareholders' equity | −$777.6M | −$859.5M | $300.6M |
| Cash flow | |||
| Operating cash flow | −$76.4M | −$69.0M | −$54.0M |
| Capital expenditure | $6.11M | $4.36M | $5.03M |
| Free cash flow | −$82.5M | −$73.4M | −$59.0M |
| Share buybacks | $228.0K | — | — |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $32.9M | $35.0M | $37.2M | $43.4M | $46.3M | $49.1M | $52.6M | $64.1M |
| Growth (year over year) | — | — | +38.6% | +39.8% | +40.5% | +40.5% | +41.3% | +47.6% |
| Gross profit | $24.9M | $26.3M | $27.9M | $32.8M | $35.4M | $39.1M | $42.2M | $53.2M |
| Gross margin | 75.7% | 75.0% | 75.1% | 75.5% | 76.5% | 79.5% | 80.2% | 83.0% |
| Operating income | −$14.9M | −$16.1M | −$17.5M | −$13.7M | −$15.1M | −$17.8M | −$29.5M | −$17.9M |
| Operating margin | −45.3% | −45.9% | −47.0% | −31.6% | −32.6% | −36.1% | −56.1% | −27.9% |
| Net income | −$19.1M | −$33.0M | −$32.3M | −$9.20M | −$50.9M | −$24.4M | −$27.4M | −$15.7M |
| Net margin | −58.1% | −94.3% | −86.9% | −21.2% | −109.9% | −49.7% | −52.1% | −24.6% |
| EPS (diluted) | −$3.43 | −$5.66 | −$5.25 | −$1.46 | −$1.04 | $4.58 | −$0.32 | −$0.18 |
| Balance sheet | ||||||||
| Cash and equivalents | $64.7M | $51.4M | $109.8M | $80.2M | $291.2M | $44.8M | $19.7M | $34.4M |
| Total assets | — | $118.7M | — | $159.4M | $364.4M | $359.5M | $344.0M | $344.5M |
| Total liabilities | — | $209.6M | — | $285.6M | $109.8M | $58.8M | $58.3M | $64.7M |
| Shareholders' equity | −$830.6M | −$859.5M | −$889.0M | −$894.8M | $254.6M | $300.6M | $285.7M | $279.7M |
| Cash flow | ||||||||
| Operating cash flow | −$10.3M | −$14.0M | −$13.2M | −$27.3M | −$2.96M | −$10.6M | −$30.1M | −$8.58M |
| Capital expenditure | $1.02M | $332.0K | $1.10M | $790.0K | $1.24M | $1.90M | $1.89M | $1.92M |
| Free cash flow | −$11.3M | −$14.4M | −$14.3M | −$28.1M | −$4.19M | −$12.5M | −$32.0M | −$10.5M |
From Heartflow Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Heartflow Inc
- Headquarters
- San Francisco, California From SEC filings, Oct 2026
Recent News (2)
-
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026 SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it…
-
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced th…
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International